Epistem Share Discussion Threads

[the ghost who walks] 28/10/2014 17:34

Yes seems prettyn promising.

[rambutan2] 28/10/2014 10:56

Results out and Genedrive making progress, so not so bad imho.

[azzi] 26/10/2014 19:37

There must be some problem as EHP should be well on track to deliver on their promise to launch the Genedrive Tb technology by the end of this year?
Bigman you are correct, I hold 2 AIM biotechs which I always say are for entertainment. The truth is I also want to make money out of them. I guess I am just fascinated to follow the psychology of AIM companies - this primarily relates to the directors. It appears to me AIM is a mechanism for some brass necked individuals free of any morals and ethics to freely spend the money of their investors whilst keeping price sensitive info very close to their chest.
So I say - time to come clean Epistem - you've talked the talk......
Azzi

[bigman] 07/10/2014 17:56

just as important when investing ( maybe more important)and buying shares is the decision to sell when you are losing money. Sometimes and more often than not when you think things are not going as expected they are not and best to take the loss and move on rather than hold on and lose more.

[bigman] 07/10/2014 17:56

just as important when investing ( maybe more important)and buying shares is the decision to sell when you are losing money. Sometimes and more often than not when you think things are not going as expected they are not and best to take the loss and move on rather than hold on and lose more.

[azzi] 02/10/2014 19:30

Looking at the share price decline, I am sensing there is bad news in the forecast. Does anyone have any progress updates?

[azzi] 14/9/2014 11:34

I would like to see a progress update on the Genedrive system - I thought it was due to be launched by the end of 2014. Still a few months to go I appreciate, but I am not getting any positive vibes at all. Does anyone have any info as I have searched and come up with nothing?

[buywell2] 23/8/2014 08:35

Which means 'stock picking' is the name of the game

Those with a good CEO and about to break into profit after several years of revenue growth

[azzi] 22/8/2014 20:55

Thanks for the info folks! I haven't had much time to follow EHP's progress over the past week so just catching up. EHP is one of only two Aim stocks I hold, unfortunately both are behaving as do most AIM stocks - chaotic. We need some very positive progress updates, no bad news, no excuses. High Risk - High Reward (but not always high reward on aim!!)
Az.

[the ghost who walks] 10/8/2014 14:48

Azzi the following link is quite good, albeit slightly old now.

[bigman] 06/8/2014 07:54

Azzi- when I first invested in this I believed the story on genedrive which was the next big thing at the time following the other previous "next big thing" that brought them to market it was going to revolutionise the NH with a test done in this machine you don't need a doctor and you will know what you are going to get disease wise/when that will be and when you will die. I exaggerate of course but it was doing so much, over the years it was going to be launched ever year and it always seemed to be next year, it then morphed into something for developing countries, mmhhh. I am sure a short time on google will throw up bill gates foundation and how they work and drive down cost of tests, who they work with and lots more, you are right to be annoyed with yourself for not doing the research, I did the same and learned to my cost. it is always tomorrow That is a problem investing in AIM and flash accounts with lots of pictures "oh how good we are" don't let the story get in the way of facts ! look at the numbers.

[azzi] 05/8/2014 21:20

OK - I am annoyed with myself for not doing enough research on Epistem before my last share purchase. It appears they have a significant competitor who are competing for exactly the same Tb market in India. The company is Cepheid who have their own instrument and chemistry and appear to offer an identical assay for "MTB/ RIF" They claim their test takeS up to 2 hours, EHP's takes 1 hour. However they are actively working with the World Health Organisation (and have been since 2010) to endorse the use of their technology, there is a mass of information on the reliability and effectiveness of their Tb test. I am worried that in all my reading this evening I have found no mention of Epistem!! it seems that they are lagging their competitor by at least 3 years - please will somebody tell me that I am wrong! I have over £50k invested with this outfit.
On a positive note there appears to be a WHO and government agreement that any Tb test in India will be capped at about $25 per test, this should provide ample margin for any new technology.
Az

[azzi] 05/8/2014 11:55

I have 25k shareS in EHP, sadly 15k more than the CEO! I have just checked the annual report and find that bigman is correct, the CEO pulled in 300K last year and the year before, so someone must rate him highly.
I am doing some more digging on the flagship technology and I am trying to understand the business model for launching Genedrive into developing countries. Key questions I can`t find answers to are - How much will they charrge for each genedrive unit? Understand some of this might be offset by the latest initiative, but I need more detail. What will the cost per test be of the assays that will be run on the unit? In particular, what will the be the cost per test for TB? The Indian testing regimes for Tb appear to be time consuming BUT they are cheap, about 2 to 3 US dollars.
If anyone has any answers or info then please share.
Az

[bigman] 05/8/2014 08:13

Azzi.. your comment "directors are fattening themselves". So true Matthew Wallace CEO earned £300,0000 last year, this is a small AIM company selling circa £5M a year, not a FTSE 100 company or a bank, that is ridiculous, and how much does he invest in the company ? he has 10,000 shares, I had more than that !!! it is paltry and shows his confidence in the business.
Well ladyfarmer, you may think that is positive, (which it may wellbe), but simply it is borrowing money at 5% interest and a commitment to sell the products cheap in developing countries, ( assuming it actually does sell ) and boy does it need the money, losses doubling, turnover down, consumption of cash up, dose not bode well. but hey on the positive side, there is always "tomorrow"

[azzi] 04/8/2014 21:38

I was an investor hear quite a few years ago and made a fair paper profit which evaporated last Autumn. I sold out but foolishly I re-invested as I believed in Genedrive etc, unfortunately I am increasingly suspicious that not all is going to plan with the technology, the Indian TB launch was scheduled for the second half of this year but there appears to be no progress update to ease my worries.
I'll stick with it for another month or two, however I agree with bigman - all promises and nothing delivered. Yet another AIM company where the directors are fattening themselves upon the investors money....sorry to be so cynical and negative.
Az

[bigman] 01/8/2014 20:07

Glad I got out of this, best of luck to you holders, looks like it is all promises and nothing else except consume cash

[rambutan2] 01/8/2014 15:35

Certainly needing a long time horizon, but I was very encouraged by the GHIF backing. It's its first investment, so they'd be trying their best not to choose a duff one you'd have thought.

[asph] 01/8/2014 10:51

I have been loyal --but this is ridiculous !

[ladyfarmer] 22/7/2014 09:28

Yes I agree. Note the conversion price? £4.89. Nice to have a benchmark

[the ghost who walks] 22/7/2014 09:08

this seems pretty significant

[ladyfarmer] 22/7/2014 07:59

Here you go:

[asph] 16/7/2014 10:01

really disappointed with this holding ----can only hope for breakthrough of some sort

[cosmos1] 16/7/2014 09:33

Any particular reason for the movement down today...?